SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001802768-21-000016
Filing Date
2021-05-11
Accepted
2021-05-11 09:03:09
Documents
81
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rprx-20210331.htm   iXBRL 10-Q 2122431
2 EX-31.1 rprx-20210331ex311.htm EX-31.1 8727
3 EX-31.2 rprx-20210331ex312.htm EX-31.2 8764
4 EX-32 rprx-20210331ex32.htm EX-32 5392
  Complete submission text file 0001802768-21-000016.txt   9738980

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rprx-20210331.xsd EX-101.SCH 71886
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rprx-20210331_cal.xml EX-101.CAL 112428
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rprx-20210331_def.xml EX-101.DEF 481545
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rprx-20210331_lab.xml EX-101.LAB 790834
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rprx-20210331_pre.xml EX-101.PRE 567996
10 EXTRACTED XBRL INSTANCE DOCUMENT rprx-20210331_htm.xml XML 1649523
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39329 | Film No.: 21909826
SIC: 2834 Pharmaceutical Preparations